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Background: Teenagers and young adults (TYA, 15–24 years) diagnosed with cancer report repeated visits to primary care before
referral. We investigated associations of symptoms and consultation frequency in primary care with TYA cancers.
Methods: Population-based, case–control study was carried out using data from the Clinical Practice Research Datalink (CPRD).
A total of 1064 TYA diagnosed with cancer were matched to 13 206 controls. Symptoms independently associated with specific
cancers were identified. Likelihood ratios (LRs) and positive predictive values (PPVs) were calculated.
Results: In the 3 months before diagnosis, 397 (42.9%) cases consulted X4 times vs 593(11.5%) controls (odds ratio (OR): 12.1;
95% CI: 9.7, 15.1), yielding a PPV for any cancer of 0.018%. The LR of lymphoma with a head/neck mass was 434 (95% CI: 60, 3158),
with a PPV of 0.5%. Corresponding figures in other cancers included – LR of leukaemia with lymphadenopathy (any site): 29
(95% CI: 8, 112), PPV 0.015%; LR of CNS tumour with seizure: 56 (95% CI: 19, 163), PPV 0.024%; and LR of sarcoma with
lump/mass/swelling: 79 (95% CI: 24, 264), PPV 0.042%.
Conclusion: Teenagers and young adults with cancer consulted more frequently than controls in the 3 months before diagnosis.
Primary care features of cancer match secondary care reports, but were of very low risk; nonetheless, some features increased the
likelihood of cancer substantially and should be taken seriously when assessing TYA.
Teenagers and young adults (TYA, 15–24 years) with cancer
frequently report repeated visits to primary care before referral for
investigation (Smith et al, 2007). Improving early diagnosis is a
priority for TYA (Smith et al, 2007), reflected in UK cancer policy
(Department of Health, 2007, 2011). Delayed diagnosis reduces the
confidence of patients and parents in their doctor (Dixon-Woods
et al, 2001; Larsen et al, 2011), but its impact on survival in TYA is
unknown.
Potential cancer diagnoses are diverse in this age group, early
symptoms are often nonspecific, may be explained by more
common illnesses and, because cancer in TYAs is rare (Birch et al,
2002), are low on the list of differential diagnoses for a general
practitioner (GP). The aim of this study was to investigate the risk
of cancer in TYA presenting to primary care with symptoms and/
or increased consultation frequency.
METHODS
Study design. This was a population-based, case–control study
nested within a cohort of TYA registered with the UK Clinical
Practice Research Datalink (CPRD) (www.cprd.com). The CPRD is
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a prospectively gathered, anonymised database that holds long-
itudinal administrative, clinical and prescribing records (including
all consultations and diagnoses) of 11 million patients, from over
600 general practices across the UK (covering approximately 8% of
the population; Clinical Practice Research Datalink, 2011). Data
from the CPRD has been used in a number of studies to identify and
quantify the symptoms of cancer (Hamilton et al, 2009; Shephard
et al, 2012; Stapley et al, 2012; Dommett et al, 2012, 2013).
Study population. The sample comprised TYA aged 15–24 years,
inclusive, drawn from all GP practices contributing to the CPRD
since it was established on 1 January 1988 to 31 December 2010.
Inclusion criteria and case–control definitions are as described
previously (Dommett, 2013).
Symptoms and consultations. Consultations in the 12 months
before diagnosis were identified. Libraries of codes representing
individual features of possible cancer in TYA were assembled using
established methodology (Dommett et al, 2012, 2013). Acne was
considered to be unrelated to cancer and was included as a control
condition to identify any recording bias (patients with cancer may
attend more frequently, giving more opportunities for symptom
recording).
Analysis. The magnitudes of associations of symptoms and
patterns of consultation frequency with cancer were identified
using univariable conditional logistic regression. Only variables
occurring in X2% of either cases or controls, and with a
univariable P-value p0.1 entered the multivariable analyses
(Hamilton, 2009). We used a ‘conservative’ P-value of o0.01 for
retention in the final model, to avoid false-positive associations
arising from multiple testing. Positive predictive values (PPV) were
calculated as described previously (Dommett, 2013).
Sample sizes were predetermined by the total number of cancers
in the CPRD, so we performed a power calculation, using a two-
sided 5% significance. A study with 300 cases (e.g., lymphoma)
each with 13 controls hasB99% power to identify a change in the
prevalence of a variable from 5% in controls to 10% in cases.
For rarer cancers (e.g., bone), 80 cases had 84% power to identify a
similar change and 97% power for a change in a commoner
variable from 30% in controls to 50% in cases.
RESULTS
In all, 1064 eligible cases and 13 206 eligible controls were identi-
fied. Their cancer diagnoses are summarised in Supplementary
Table 1 online.
Consultation frequency. In the 12 months before diagnosis, cases
had a median of five consultations (interquartile range (IQR): 3–9)
compared with two (IQR: 0–4) in controls (Po0.001). Among
cases, 95.2% had consulted in the year before diagnosis compared
with 71.1% of controls (odds ratio (OR) 9.0; 95% CI: 6.8–12.1)
(Supplementary Table 2 online). Differences in consultation rates
were most apparent in the 3 months immediately before diagnosis,
cases having a median of three consultations (IQR 1–5) compared
with no consultations (IQR 0–1) in controls (Po0.001). This
difference was consistent across all diagnostic groups in both cases
and controls (Supplementary Figure 1 online).
Among cases, 86.9% had seen their GP in the 3 months before
cancer diagnosis compared with 38.8% of controls (OR: 12.4; 95%
CI: 10.3–15.0) (Table 1). Of these, 42.9% of cases had consulted
four times or more compared with 11.5% of controls (OR: 12.1;
95% CI: 9.7–15.1). However, the PPV for cancer in a TYA patient
consulting four times or more in 3 months was only 0.018%; that
is, of 10 000 TYA consulting four times or more in 3 months,
only around two would be diagnosed with cancer (based on a prior
probability of cancer of 0.49 in 10 000 in 3 months) (Birch et al,
2002).
Identification of independent associations with cancer. Because
of the diversity of diagnoses in our cohort, symptom analysis
was limited to four predefined disease groups: leukaemia (annual
incidence: 0.21 per 10 000); lymphoma (annual incidence: 0.47 per
10 000); CNS tumours (annual incidence: 0.17 per 10 000);
and bone/soft tissue sarcoma (annual incidence: 0.21 per 10 000)
(Birch et al, 2002). The multivariable models for each group are
shown in Table 2.
Four features remained in the final model for leukaemia,
of which lympadenopathy had the highest PPV of 1.5 per 10 000
(95% CI: 0.4–5.78).
Four features remained in the final model for lymphoma,
of which lump/mass/swelling of the head and neck had the highest
PPV of 50.34 per 10 000 (95% CI: 6.96–367.86). The second highest
PPV was for lymphadenopathy followed by lump/mass/swelling
Table 1. The association between the number of consultationsa and a diagnosis of cancer
Case
N¼1064
Control
N¼13206
Number of
consultations Freq. %c Freq. %c ORb Likelihood ratio
Positive predictive
value (per 10000)
(95% CI)
0–3 months before index date
No consultatios 139 13.06 8071 61.12 1.0
With consultations 925 86.94 5135 38.88 12.4 (10.3–15.0) 2.24 1.1 (1.07–1.14)
1 195 21.08 2860 55.70 1.0
2 190 20.54 1150 22.40 2.6 (2.1–3.2) 0.92 0.45 (0.39–0.52)
3 143 15.46 532 10.36 4.5 (3.5–5.8) 1.49 0.73 (0.62–0.87)
4 or more 397 42.92 593 11.55 12.1 (9.7–15.1) 3.72 1.83 (1.65–2.04)
Abbreviations: CI¼ confidence interval; Freq.¼ frequency; GP¼general practitioner; OR¼odds ratio.
aAll primary care consultations including out of hours and telephone consultations.
bRepresents the odds of being diagnosed with cancer given more consultations with the GP; computed using conditional logistic regression.
cFor categories 1, 2, 3 and 4 or more, proportions reflect only patients with consultations.
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Table 2. Multivariable analysis of the features of specific TYA cancers: (A) leukaemia, (B) lymphoma, (C) CNS tumours and (D) bone tumour/soft tissue
sarcoma
(A) Leukaemia
Cases
(N¼143)
Control
(N¼1799)
Symptoma Freq. % Freq. % OR
95%
Confidence
interval P-value LR
95%
Confidence
interval
PPV (per
10000)
95%
Confidence
interval
Lymphadenopathyb 7 4.90 3 0.17 7.65 1.55–37.72 0.0124 29.35 7.67–112.30 1.51 0.40–5.78
Fatigue 15 10.49 8 0.44 12.69 4.48–35.96 o0.0001 23.59 10.17–54.69 1.21 0.52–2.82
Bruising 9 6.29 5 0.28 24.72 4.71–129.78 o0.0002 22.64 7.69–66.67 1.17 0.40–3.43
Three or more
consultations
74 51.75 125 6.95 5.92 3.71–9.44 o0.0001 7.45 5.91–9.39 0.38 0.30–0.48
(B) Lymphoma
Cases
(N¼270)
Control
(N¼3350)
Symptoma Freq. % Freq. % OR
95%
Confidence
interval P-value LR
95%
Confidence
interval
PPV (per
10000)
95%
Confidence
interval
Lump mass swelling
head and neck
35 12.96 1 0.03 71.85 8.98–575.07 0.0001 434.26 59.72–3157.62 50.34 6.96–367.86
Lymphadenopathy 77 28.52 4 0.12 184.46 40.65–837.06 o0.0001 238.84 88.09–647.59 27.75 10.26–75.44
Lump mass swellingc 29 10.74 15 0.45 14.08 5.33–37.19 o0.0001 23.99 13.02–44.19 2.79 1.52–5.15
Three or more
consultations
175 64.81 294 8.78 7.67 4.92–11.95 o0.0001 7.39 6.42–8.50 0.86 0.75–0.99
(C) CNS tumours
Cases
(N¼154)
Control
(N¼1906)
Symptoma Freq. % Freq. % OR
95%
Confidence
interval P-value LR
95%
Confidence
interval
PPV (per
10000)
95%
Confidence
interval
Seizure 18 11.69 4 0.21 17.5 5.12–59.83 o0.0001 55.69 19.09–162.52 2.38 0.82–6.95
Headache 33 21.43 12 0.63 18.91 7.11–50.25 o0.0001 34.04 17.95–64.55 1.45 0.77–2.76
Vomiting 11 7.14 5 0.26 7.31 1.65–32.47 0.0089 27.23 9.58–77.37 1.16 0.41–3.31
Pain 11 7.14 20 1.05 6.11 2.25–16.57 0.0004 6.81 3.32–13.95 0.29 0.14–0.6
Three or more
consultations
73 47.4 165 8.66 3.04 1.82–5.09 o0.0001 5.48 4.39–6.83 0.23 0.19–0.29
(D) Bone tumours/soft tissue sarcoma
Cases
(N¼196)
Control
(N¼2438)
Symptoma Freq. % Freq. % OR
95%
Confidence
interval P-value LR
95%
Confidence
interval
PPV (per
10000)
95%
Confidence
interval
Lump mass
swelling
19 9.69 3 0.12 39.62 8.17–192.1 o0.0001 78.78 23.52–263.91 4.15 1.24–13.92
Musculoskeletal
symptoms
37 18.88 26 1.07 8.37 4.18–16.76 o0.0002 17.7 10.95–28.61 0.93 0.58–1.51
Three or more
consultations
86 43.88 189 7.75 3.88 2.48–6.06 o0.0003 5.66 4.59–6.98 0.3 0.24–0.37
Chest painb 5 2.55 12 0.49 5.15 1.47–17.99 0.0103 5.18 1.84–14.56 0.27 0.1–0.77
Abbreviations: CNS¼ central nervous system; Freq.¼ frequency; LR¼ likelihood ratio; OR¼odds ratio; PPV¼positive predictive value; TYA¼ teenagers and young adults.
aSymptoms are ordered by PPV.
bHas a P-value below the threshold, but is needed in the model based on the LR test.
cLump mass swelling below neck not including abdomen.
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below neck excluding abdomen, and it is presumed that all three of
these features are likely to represent lymphadenopathy. When
lump/mass/swelling of the head and neck, lymphadenopathy and
lump/mass/swelling below neck excluding abdomen are combined
as a single symptom the PPV is 9.03 per 10 000 (95% CI:
5.73–14.25).
The CNS tumour model contained five features, with seizure
having the highest PPV of 2.38 per 10 000 (95% CI: 0.82–6.95).
In this group, 8.4% of cases had visual symptoms, but a PPV could
not be calculated as no controls had this feature.
Four variables were independently associated with bone/soft
tissue sarcomas, with lump/mass/swelling below neck, excluding
abdomen, having the highest PPV of 4.15 per 10 000 (95% CI:
1.24–13.92).
The OR and LR for our control condition, acne, were 1.32
(95% CI: 0.8–2.19) and 1.31 (95% CI: 0.8–2.14), respectively,
indicating little evidence of recording bias.
DISCUSSION
This is the first study of TYA cancer to use prospectively collected
primary care data. The distribution of cancers was largely
representative of the diagnoses seen in TYA, with lymphoma the
most common diagnosis overall (25.4%). We chose to study
symptoms and consultations in the 3 months before a diagnosis.
This was a practical compromise, being a period over which it is
clinically reasonable for a GP to monitor symptoms.
Teenagers and young adults with cancer see their doctors
more frequently than controls, particularly in the 3 months
before diagnosis. Even so, because TYA cancer is rare, the
absolute risk of cancer in a patient consulting four or more
times is only 1.8 per 10 000. The consultation rates observed are
consistent with retrospective case note analyses (Fern, et al, 2011)
and patient reports (Lyratzopoulos et al, 2012; Smith et al, 2007).
The high percentage of patients with multiple consultations may
represent the complexity of a cancer diagnosis in this age group
and supports advice advocating referral if a patient attends
several times with the same problem, without a clear diagnosis
(National Institute for Health and Clinical Excellence, 2005).
The use of electronic primary care records has limitations as it is
well recognised that GPs preferentially record diagnoses as
opposed to unexplained symptoms. Under-recording should
not affect likelihood ratios (which underpin PPVs) as long as it
is consistent between cases and controls, but may lead to
an overestimation of PPVs, and they will only remain valid if
GP recording and patient consultation behaviour do not change
with time (Hamilton, 2012; Shapley et al, 2010).
Our findings confirm the clinical significance of the commonly
perceived symptoms of cancer in this age group, as expected
symptom patterns emerged for the different diagnostic groups
closely matching reports from secondary care. Absolute risks of
specific cancers with symptoms have not been estimated
previously, although we expected them to be small. Yet, despite
the small absolute risks, some features substantially altered the
prior probability of a subsequent diagnosis of cancer. The presence
of a lump, mass or swelling of the head and neck increased the
prior probability of lymphoma from 0.12 per 10 000
in any 3-month period to a posterior probability of
50.3 per 10 000, a more than 400-fold increase in probability. Of
note, visual symptoms were not recorded in controls, but were
frequent in CNS tumours, implying that investigation is clearly
appropriate.
As TYA cancer diagnosis is rare, PPVs will never be particularly
high; thus, the question for primary care remains: should a raised
relative risk trigger investigation, even when the absolute risk is
very small? We believe the seriousness of TYA cancer, coupled
with the high potential for cure, justifies investigation at a lower
level of probability than might be considered appropriate for later
onset adult cancers. Safety-netting procedures are particularly
appropriate where, for example, non-resolving musculoskeletal
symptoms follow a minor sports injury, may be indicative of a
bone/soft tissue sarcoma. This may be especially relevant in this
age group as TYAs evolve towards independent health-care-
seeking behaviour.
CONCLUSION
The perception of delay in diagnosis in TYA can have major
implications on their subsequent cancer journey. The symptoms
identified for common cancers in this age group are not
unexpected, but some substantially alter the prior probability of
a cancer diagnosis. NICE guidance for recognition of suspected
cancer is currently being updated in the United Kingdom and the
symptoms reported here should enhance the credibility of new
recommendations, as they derive from primary care data. Further
studies of TYA consultation behaviour and of how symptoms are
interpreted both by the GP and the patient are required to fully
understand their impact on time to diagnosis, and on how this can
be minimised.
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